IRIS
SAVARINO, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 52.674
NA - Nord America 5.421
AS - Asia 5.129
Continente sconosciuto - Info sul continente non disponibili 639
SA - Sud America 491
AF - Africa 93
OC - Oceania 8
Totale 64.455
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 51.812
US - Stati Uniti d'America 5.017
SG - Singapore 2.067
CN - Cina 1.268
VN - Vietnam 733
BD - Bangladesh 509
FR - Francia 427
BR - Brasile 284
HK - Hong Kong 180
CA - Canada 156
DE - Germania 90
FI - Finlandia 81
MX - Messico 78
AR - Argentina 72
IN - India 69
GB - Regno Unito 68
JP - Giappone 55
IQ - Iraq 41
NL - Olanda 35
VE - Venezuela 31
JM - Giamaica 30
CO - Colombia 29
EC - Ecuador 29
CR - Costa Rica 28
ID - Indonesia 28
CH - Svizzera 27
CL - Cile 22
ES - Italia 21
TR - Turchia 19
GT - Guatemala 17
HN - Honduras 17
MY - Malesia 16
NI - Nicaragua 16
PH - Filippine 15
TH - Thailandia 15
TT - Trinidad e Tobago 15
IE - Irlanda 14
NP - Nepal 14
RU - Federazione Russa 14
ZA - Sudafrica 14
SA - Arabia Saudita 13
KE - Kenya 12
PE - Perù 12
PL - Polonia 12
JO - Giordania 11
MA - Marocco 11
SV - El Salvador 11
PK - Pakistan 10
UA - Ucraina 10
PR - Porto Rico 8
SC - Seychelles 8
SE - Svezia 8
TW - Taiwan 8
AU - Australia 7
KR - Corea 7
LT - Lituania 7
DZ - Algeria 6
OM - Oman 6
TN - Tunisia 6
AT - Austria 5
BB - Barbados 5
BH - Bahrain 5
PY - Paraguay 5
SI - Slovenia 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
BY - Bielorussia 4
EE - Estonia 4
PA - Panama 4
PT - Portogallo 4
SN - Senegal 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
BZ - Belize 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
EG - Egitto 3
ET - Etiopia 3
IL - Israele 3
IR - Iran 3
KG - Kirghizistan 3
RO - Romania 3
SY - Repubblica araba siriana 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
CG - Congo 2
CZ - Repubblica Ceca 2
GP - Guadalupe 2
GR - Grecia 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
LC - Santa Lucia 2
LK - Sri Lanka 2
LY - Libia 2
ME - Montenegro 2
MN - Mongolia 2
MQ - Martinica 2
NG - Nigeria 2
Totale 63.772
Salva come PNG Salva come JPEG
Città #
Genova 33.728
Genoa 10.473
Rapallo 4.096
Vado Ligure 2.886
San Jose 1.155
Singapore 935
Ashburn 519
Lauterbourg 400
New York 262
Ho Chi Minh City 223
Beijing 195
Hong Kong 174
Hanoi 165
Santa Clara 153
Los Angeles 121
Council Bluffs 84
Dallas 82
Milan 78
Phoenix 78
Helsinki 77
Rome 76
Chicago 73
Frankfurt am Main 68
Orem 65
Bordighera 62
Buffalo 49
Atlanta 47
Mexico City 46
San Francisco 46
Tokyo 46
Philadelphia 38
Da Nang 34
Naples 34
Brooklyn 32
Toronto 31
Tianjin 27
Bologna 26
Haiphong 26
Amsterdam 25
Montreal 25
St Louis 25
Zurich 25
Boardman 23
Denver 23
São Paulo 23
Chennai 22
San José 22
Washington 21
Brasília 20
Houston 20
Kingston 20
Florence 18
Memphis 17
Hải Dương 16
The Bronx 16
Guangzhou 15
Jacksonville 15
Queens 15
Seattle 15
Boston 14
Managua 14
Miami 14
Mumbai 14
Poplar 14
Baghdad 13
Dublin 13
Las Vegas 13
Pittsburgh 13
Charlotte 12
Figino 12
Amman 11
Guatemala City 11
Medford 11
Quito 11
San Antonio 11
San Salvador 11
Shanghai 11
Warsaw 11
Bari 10
City of London 10
Cleveland 10
Nairobi 10
Padua 10
Palermo 10
Rio de Janeiro 10
Sacramento 10
Biên Hòa 9
Columbus 9
Curitiba 9
Guayaquil 9
Kuala Lumpur 9
Louisville 9
Richmond 9
Rochester 9
Turin 9
Austin 8
Bangkok 8
Can Tho 8
Cardiff 8
Chaguanas 8
Totale 57.566
Salva come PNG Salva come JPEG
Nome #
Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG) 340
Assessment of Intestinal Permeability Using Sugar Probes: Influence of Urinary Volume 322
Proton pump inhibitors: use and misuse in the clinical setting 253
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. 250
Hepatobiliary and Pancreatic: A rare cause of portal hypertension. 249
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. 238
5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for “best evidence”? 234
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 230
Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis 229
A pharmacodynamic study of two omeprazole regimens suitable for long-term treatment of duodenal ulcer. 226
Comparison of Two Different Techniques to Assess Adalimumab Trough Levels in Patients with Crohn's Disease. 225
Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index 221
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. 220
Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease 217
Positive PET in a patient with esophageal leiomyoma. 216
Measurement of oro-caecal transit time by magnetic resonance imaging. 214
13C-mixed triglyceride (13C-MTG) breath-test (BT) in Cystic Fibrosis (CF). 211
Time pattern of gastric acidity in Barrett's esophagus 210
Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group 210
A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms. 209
Are proton pump inhibitors really so dangerous? 208
Circadian monitoring of gastric juice mutagenicity. 207
Measurement of sorafenib plasma concentration by high-performance liquid chromatography in patients with advanced hepatocellular carcinoma: is it useful the application in clinical practice? A pilot study 206
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial 205
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD) 205
A safety review of proton pump inhibitors to treat acid-related digestive diseases 205
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. 204
Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease. 204
Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on follow-up 202
Alginate controls heartburn in patients with erosive and nonerosive reflux disease. 202
Barrett's esophagus in 2016: From pathophysiology to treatment 202
Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD) 201
High anti-TNF alfa drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel disease 200
Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial. 199
24-hour study of intragastric acidity in duodenal ulcer patients and normal subjects using continuous intraluminal pH-metry. 198
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 197
A study of 4-and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication 197
Improvement in esophageal motor abnormalities in systemic sclerosis patients treated with cyclosporine: comment on the article by Clements et al. 196
Drugs for improving esophageal mucosa defense: Where are we now and where are we going? 196
A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine. 195
Breath tests to assess alcoholic liver disease. 195
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD 195
Ilaprazole for the treatment of gastro-esophageal reflux 195
Outcome of nonerosive gastro-esophageal reflux disease patients with pathological acid exposure. 194
A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics. 191
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. 190
24-hour gastric pH and extent of duodenal gastric metaplasia in Helicobacter pylori-positive patients. 188
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? 188
A Comparison Between Lactose Breath Test and Quick Test on Duodenal Biopsies for Diagnosing Lactase Deficiency in Patients With Self-reported Lactose Intolerance. 187
Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia. 187
Association Between Baseline Impedance Values and Response Proton Pump Inhibitors in Patients With Heartburn 185
The role of small intestinal bacterial overgrowth in rosacea: A 3-year follow-up 185
An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry. 184
Circadian reduction of chromium in the gastric environment. 184
A comparison of five maintenance therapies for reflux esophagitis 183
Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy 183
24-H comparison between pH values of continuous intraluminal recording and simultaneous gastric aspiration. 182
Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Patients With Reflux Disease 182
Can artificial neural networks be beneficial in diagnosing gastro-oesophageal reflux disease? 180
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine. 179
Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity. 179
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study. 178
Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer. 177
Burden of illness in Italian patients with gastro-oesophageal reflux disease. 176
Acid and gastric metaplasia in the duodenum 175
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 175
Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn’s disease. 174
Anti-TNF Antibodies For Prevention of Crohn's Disease Recurrence After Surgery: More Than An Hope. 174
Reduction in TIMP-2 serum levels predicts remission of inflammatory bowel diseases 174
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations 174
Starry Liver: An Unexpected Diagnosis 173
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. 173
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure 173
Improvement in Waldenstrom’s macroglobulinemia after successful treatment of HCV with direct-acting antivirals 173
Circadian acidity pattern in prepyloric ulcers: a comparison with normal subjects and duodenal ulcer patients. 172
Adalimumab trough levels and response to biological treatment in patients with Inflammatory Bowel Disease: a useful cut-off In clinical practice. 172
Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. 172
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori. 171
A Nodule, is a Nodule, is a Nodule: May Alpha-fetoprotein Make the Difference? 171
Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals 171
Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum. 170
Impact of evidence-based medicine on treatment of patients with unresectable hepatocellular carcinoma 168
Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives 168
Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients 168
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 168
13C-octanoic ac. Breath test: neural network analysis of 13C excretion data 167
Successful antiviral therapy determines a significant decrease in squamous cell carcinoma antigen-associated (SCCA) variants' serum levels in anti-HCV positive cirrhotic patients. 166
External Validation of the Platelet Count/Spleen Diameter Ratio for the Diagnosis of Esophageal Varices in Hepatitis C Virus-Related Cirrhosis 166
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens 165
Comparison between laparoscopy, ultrasonography, and computed tomography in widespread and localized liver diseases. 165
24-hour gastric pH-metry analysis: influence of arbitrarily predefined time intervals on the reliability of acidity indexes. 165
Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulphate based bioadhesive formulation 165
The appropriate use of proton-pump inhibitors 165
Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring. 164
A single-blind pilot study comparing standard and half bedtime doses of ranitidine in the short-term healing of duodenal ulcer. 164
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. 164
An independent validation of the mortality score for the short-term prognostic prediction in patients with chronic hepatitis C virus infection and advanced liver disease 163
24-hour study of gastric acidity in normal subjects and in cholecystectomized patients using continuous pH monitoring. 163
Microscopic Esophagitis is More Frequent in Patients With pH-Positive Non-Erosive Reflux Disease and Hypersensitive Esophagus Than in Those With Functional Heartburn: A Study Using Impedance-pH and Optical Microscopy. 163
Low serum trough levels are associated with post-surgical recurrence in Crohn's disease patients undergoing prophylaxis with adalimumab. 163
Totale 19.277
Salva come PNG Salva come JPEG
Categoria #
all - tutte 201.632
article - articoli 187.887
book - libri 542
conference - conferenze 2.949
curatela - curatele 0
other - altro 9.916
patent - brevetti 0
selected - selezionate 0
volume - volumi 338
Totale 403.264
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.783 0 0 378 744 235 408 388 1.125 212 497 177 619
2022/20234.913 530 265 60 424 947 890 6 379 886 32 437 57
2023/20242.217 117 319 50 224 185 396 129 100 138 39 142 378
2024/20257.016 275 599 263 452 959 718 570 1.066 279 293 695 847
2025/202612.730 1.420 298 927 1.117 1.408 1.476 2.042 553 810 1.184 660 835
2026/20273.324 1.628 664 1.032 0 0 0 0 0 0 0 0 0
Totale 64.455